Cited by 343Diabetes Management and ResearchDiabetes Management and EducationDiabetes and associated disorders

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Glycaemic control of Type 1 diabetes in clinical practice early in the 21st century: an international comparison

Open access

McKnight, J. A., Wild, S. H., Lamb, M. J. E., Cooper, M. N., Jones, T. W., Davis, E. A., Hofer, S., Fritsch, M., Schober, E., Svensson, J., Almdal, T., Young, R., Warner, J. T., Delemer, B., Souchon, P. F., Holl, R. W., Karges, W., Kieninger, D. M., Tigas, S., Bargiota, A., Sampanis, C., Cherubini, V., Gesuita, R., Strele, I., Pildava, S., Coppell, K. J., Magee, G., Cooper, J. G., Dinneen, S. F., Eeg‐Olofsson, K., Svensson, A.‐M., Gudbjornsdottir, S., Veeze, H., Aanstoot, H.‐J., Khalangot, M., Tamborlane, W. V., Miller, K. M.·2015·Diabetic Medicine

DOI 10.1111/dme.12676

Open this paper in CoChat — free account

Abstract

AIMS: Improving glycaemic control in people with Type 1 diabetes is known to reduce complications. Our aim was to compare glycaemic control among people with Type 1 diabetes using data gathered in regional or national registries. METHODS: Data were obtained for children and/or adults with Type 1 diabetes from the following countries (or regions): Western Australia, Austria, Denmark, England, Champagne-Ardenne (France), Germany, Epirus, Thessaly and Thessaloniki (Greece), Galway (Ireland), several Italian regions, Latvia, Rotterdam (The Netherlands), Otago (New Zealand), Norway, Northern Ireland, Scotland, Sweden, Volyn (Ukraine), USA and Wales) from population or clinic-based registries. The sample size with available data varied from 355 to 173 880. Proportions with HbA1c < 58 mmol/mol (< 7.5%) and ≥ 75 mmol/mol (≥ 9.0%) were compared by age and sex. RESULTS: Data were available for 324 501 people. The proportions with HbA1c 58 mmol/mol (< 7.5%) varied from 15.7% to 46.4% among 44 058 people aged < 15 years, from 8.9% to 49.5% among 50 766 people aged 15-24 years and from 20.5% to 53.6% among 229 677 people aged ≥ 25 years. Sex differences in glycaemic control were small. Proportions of people using insulin pumps varied between the 12 sources with data available. CONCLUSION: These results suggest that there are substantial variations in glycaemic control among people with Type 1 diabetes between the data sources and that there is room for improvement in all populations, especially in young adults.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1111/dme.12676

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Standards of medical care in diabetes—2013
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s011 · Cited by 4,369
Retinopathy and Nephropathy in Patients with Type 1 Diabetes Four Years after a Trial of Intensive Therapy
(2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420603 · Cited by 1,534
Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial
(2002) · BMJ · doi:10.1136/bmj.325.7367.746 · Cited by 916
Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes : dose adjustment for normal eating (DAFNE) randomised controlled trial
Amiel, S. A., Beveridge, S., Bradley, C., Gianfrancesco, C., Heller, S. R., James, P., McKeown, N., Newton, D. F., Newton, L. D., Oliver, L., et al. (2002) · Deakin Research Online (Deakin University) · Cited by 723
The T1D exchange clinic registry
Beck, R. W., Tamborlane, W. V., Bergenstal, R. M., Miller, K. M., DuBose, S. N., Hall, C. A., & for the T1D Exchange Clinic Network (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1561 · Cited by 456
Self-citation
Most Youth With Type 1 Diabetes in the T1D Exchange Clinic Registry Do Not Meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes Clinical Guidelines
Wood, J., Miller, K. M., Maahs, D. M., Beck, R. W., DiMeglio, L. A., Libman, I. M., Quinn, M., Tamborlane, W. V., & Woerner, S. E. (2013) · Diabetes Care · doi:10.2337/dc12-1959 · Cited by 422
Self-citation
Comparison of Metabolic Control in a Cross-Sectional Study of 2,873 Children and Adolescents With IDDM from 18 Countries
Mortensen, H. B., Hougaard, P., & For the Hvidøre Study Group on Childhood Diabetes (1997) · Diabetes Care · doi:10.2337/diacare.20.5.714 · Cited by 403
Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study
Stephenson, J., Fuller, J., & EUROBIAB IDDM Complications Study Group (1994) · Diabetologia · doi:10.1007/bf00398055 · Cited by 345

Show all 18 references

Research works printed but not linked: 1

Scottish Intercollegiate Guidelines Network, 2010, Management of Diabetes: A National Clinical Guideline

Sorted by citations

State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016–2018
Foster, N. C., Beck, R. W., Miller, K. M., Clements, M. A., Rickels, M. R., DiMeglio, L. A., Maahs, D. M., Tamborlane, W. V., Bergenstal, R., Smith, E., et al. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0384 · Cited by 1,907
Self-citation
Type 1 diabetes immunotherapy using polyclonal regulatory T cells
Bluestone, J. A., Buckner, J. H., Fitch, M., Gitelman, S. E., Gupta, S., Hellerstein, M. K., Herold, K. C., Lares, A., Lee, M. R., Li, K., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aad4134 · Cited by 1,033
Exercise management in type 1 diabetes: a consensus statement
Riddell, M. C., Gallen, I. W., Smart, C. E., Taplin, C. E., Adolfsson, P., Lumb, A. N., Kowalski, A., Rabasa-Lhoret, R., McCrimmon, R. J., Hume, C., et al. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30014-1 · Cited by 903
Self-citation
Home Use of an Artificial Beta Cell in Type 1 Diabetes
Thabit, H., Tauschmann, M., Allen, J. M., Leelarathna, L., Hartnell, S., Wilinska, M. E., Acerini, C. L., Dellweg, S., Benesch, C., Heinemann, L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1509351 · Cited by 450
Effects of sotagliflozin added to insulin in patients with type 1 diabetes
Garg, S. K., Henry, R. R., Banks, P., Buse, J. B., Davies, M. J., Fulcher, G. R., Pozzilli, P., Gesty-Palmer, D., Lapuerta, P., Simó, R., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1708337 · Cited by 417
Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial
Petrie, J. R., Chaturvedi, N., Ford, I., Brouwers, M. C. G. J., Greenlaw, N., Tillin, T., Hramiak, I., Hughes, A. D., Jenkins, A. J., Klein, B. E. K., et al. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30194-8 · Cited by 357
Empagliflozin as Adjunctive to Insulin Therapy in Type 1 Diabetes: The EASE Trials
Rosenstock, J., Marquard, J., Laffel, L. M., Neubacher, D., Kaspers, S., Cherney, D. Z., Zinman, B., Skyler, J. S., George, J., Soleymanlou, N., et al. (2018) · Diabetes Care · doi:10.2337/dc18-1749 · Cited by 363
Reasons why patients referred to diabetes education programmes choose not to attend: a systematic review
Horigan, G., Davies, M., Findlay‐White, F., Chaney, D., & COATES, V. E. (2016) · Diabetic Medicine · doi:10.1111/dme.13120 · Cited by 262
Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial
Mathieu, C., Dandona, P., Gillard, P., Senior, P., Hasslacher, C., Araki, E., Lind, M., Bain, S. C., Jabbour, S., Arya, N., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0623 · Cited by 252
Sotagliflozin in combination with optimized insulin therapy in adults with type 1 diabetes: the North American inTandem1 Study
Buse, J. B., Garg, S. K., Rosenstock, J., Bailey, T. S., Banks, P., Bode, B. W., Danne, T., Kushner, J. A., Lane, W. S., Lapuerta, P., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0343 · Cited by 234
ISPAD Clinical Practice Consensus Guidelines 2018: diabetes technologies
Sherr, J. L., Tauschmann, M., Battelino, T., de Bock, M., Forlenza, G., Roman, R., Hood, K. K., & Maahs, D. M. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12731 · Cited by 197
Diabetes and pregnancy: national trends over a 15 year period
on behalf of the SDRN Epidemiology Group, Mackin, S. T., Nelson, S. M., Kerssens, J. J., Wood, R., Wild, S. H., Colhoun, H. M., Leese, G., Philip, S., & Lindsay, R. S. (2018) · Diabetologia · doi:10.1007/s00125-017-4529-3 · Cited by 195
Self-citation
HbA1c and Hypoglycemia Reductions at 24 and 52 Weeks With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: The European inTandem2 Study
Danne, T., Cariou, B., Banks, P. L., Brändle, M., Brath, H., Franek, E., Kushner, J. A., Lapuerta, P., McGuire, D. K., Peters, A. L., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0342 · Cited by 187
Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised controlled trial
Visser, M. M., Charleer, S., Fieuws, S., De Block, C., Hilbrands, R., Van Huffel, L., Maes, T., Vanhaverbeke, G., Dirinck, E., Myngheer, N., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00789-3 · Cited by 165
Six Months of Hybrid Closed-Loop Versus Manual Insulin Delivery With Fingerprick Blood Glucose Monitoring in Adults With Type 1 Diabetes: A Randomized, Controlled Trial
McAuley, S. A., Lee, M. H., Paldus, B., Vogrin, S., de Bock, M. I., Abraham, M. B., Bach, L. A., Burt, M. G., Cohen, N. D., Colman, P. G., et al. (2020) · Diabetes Care · doi:10.2337/dc20-1447 · Cited by 158
Self-citation
ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Insulin delivery
Sherr, J. L., Schoelwer, M., Dos Santos, T. J., Reddy, L., Biester, T., Galderisi, A., van Dyk, J. C., Hilliard, M. E., Berget, C., & DiMeglio, L. A. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13421 · Cited by 152
Molecular and pharmacological characterization of insulin icodec: a new basal insulin analog designed for once-weekly dosing
Nishimura, E., Pridal, L., Glendorf, T., Hansen, B. F., Hubálek, F., Kjeldsen, T., Kristensen, N. R., Lützen, A., Lyby, K., Madsen, P., et al. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002301 · Cited by 159
Regulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding Trial
Todd, J. A., Evangelou, M., Cutler, A. J., Pękalski, M. Ł., Walker, N. M., Stevens, H. E., Porter, L., Smyth, D. J., Rainbow, D. B., Ferreira, R. C., et al. (2016) · PLoS Medicine · doi:10.1371/journal.pmed.1002139 · Cited by 138
SGLT2 inhibitors as adjunctive therapy for type 1 diabetes: Balancing benefits and risks
Taylor, S. I., Blau, J. E., Rother, K. I., & Beitelshees, A. L. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30154-8 · Cited by 124
Prevalence of underweight, overweight, and obesity in children and adolescents with type 1 diabetes: Data from the international SWEET registry
Maffeis, C., Birkebæk, N., Konstantinova, M. M., Schwandt, A., Vazeou, A., Casteels, K., Jali, S. M., Limbert, C., Pundziūtė-Lyckå, A., Tóth‐Heyn, P., et al. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12730 · Cited by 122
Self-citation
Diabetes technology: improving care, improving patient‐reported outcomes and preventing complications in young people with Type 1 diabetes
Prahalad, P., Tanenbaum, M. L., Hood, K. K., & Maahs, D. M. (2018) · Diabetic Medicine · doi:10.1111/dme.13588 · Cited by 125
Low-carbohydrate diets for type 1 diabetes mellitus: A systematic review
Turton, J. L., Raab, R., & Rooney, K. B. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194987 · Cited by 116
The Australasian Diabetes Data Network: first national audit of children and adolescents with type 1 diabetes
Phelan, H., Clapin, H. F., Bruns, L., Cameron, F. J., Cotterill, A. M., Couper, J., Davis, E. A., Donaghue, K. C., Jefferies, C., King, B. R., et al. (2017) · The Medical Journal of Australia · doi:10.5694/mja16.00737 · Cited by 113
Self-citation
Effect of Aerobic and Resistance Exercise on Glycemic Control in Adults With Type 1 Diabetes
Reddy, R. K. K., Wittenberg, A., Castle, J. R., Youssef, J. E., Winters‐Stone, K. M., Gillingham, M. B., & Jacobs, P. G. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2018.08.193 · Cited by 121
The SWEET Project 10-Year Benchmarking in 19 Countries Worldwide Is Associated with Improved HbA1c and Increased Use of Diabetes Technology in Youth with Type 1 Diabetes
Gerhardsson, P., Schwandt, A., Witsch, M., Kordonouri, O., Svensson, J., Forsander, G., Battelino, T., Veeze, H. J., Danne, T., & on Behalf of the SWEET Study Group (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0618 · Cited by 107
Self-citation
Exploring Variation in Glycemic Control Across and Within Eight High-Income Countries: A Cross-sectional Analysis of 64,666 Children and Adolescents With Type 1 Diabetes
Charalampopoulos, D., Hermann, J. M., Svensson, J., Skrivarhaug, T., Maahs, D. M., Åkesson, K., Warner, J., Holl, R. W., Birkebæk, N., Drivvoll, A. K., et al. (2018) · Diabetes Care · doi:10.2337/dc17-2271 · Cited by 104
Self-citation
Relative effectiveness of insulin pump treatment over multiple daily injections and structured education during flexible intensive insulin treatment for type 1 diabetes: cluster randomised trial (REPOSE)
(2017) · BMJ · doi:10.1136/bmj.j1285 · Cited by 102
Home Use of Day-and-Night Hybrid Closed-Loop Insulin Delivery in Very Young Children: A Multicenter, 3-Week, Randomized Trial
Tauschmann, M., Allen, J. M., Nagl, K., Fritsch, M., Yong, J., Metcalfe, E., Schaeffer, D., Fichelle, M., Schierloh, U. H. E., Thiele, A. G., et al. (2019) · Diabetes Care · doi:10.2337/dc18-1881 · Cited by 102
Self-citation
Ever-Increasing Insulin-Requiring Patients Globally
Garg, S. K., Rewers, A. H., & Aktürk, H. K. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0101 · Cited by 104
Care of diabetes in children and adolescents: controversies, changes, and consensus
Cameron, F. J., & Wherrett, D. K. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60971-0 · Cited by 99
A systematic review of interventions to improve outcomes for young adults with Type 1 diabetes
O’Hara, M. C., Hynes, L., O'Donnell, M. J., Nery, N., Byrne, M., Heller, S. R., Dinneen, S. F., & the Irish Type 1 Diabetes Young Adult Study Group (2016) · Diabetic Medicine · doi:10.1111/dme.13276 · Cited by 100
Self-citation
Changing the landscape for type 1 diabetes: the first step to prevention
Dayan, C. M., Korah, M., Tatovic, D., Bundy, B. N., & Herold, K. C. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32127-0 · Cited by 96
Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Kindes- und Jugendalter
Neu, A., Bürger-Büsing, J., Danne, T., Dost, A., Holder, M., Holl, R. W., Holterhus, P., Kapellen, T., Karges, B., Kordonouri, O., et al. (2016) · Diabetologie und Stoffwechsel · doi:10.1055/s-0042-111213 · Cited by 91
Self-citation
What is important for you? A qualitative interview study of living with diabetes and experiences of diabetes care to establish a basis for a tailored Patient-Reported Outcome Measure for the Swedish National Diabetes Register
Engström, M. S., Leksell, J. K., Johansson, U., & Guðbjörnsdóttir, S. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-010249 · Cited by 87
A core outcomes set for clinical trials of interventions for young adults with type 1 diabetes: an international, multi-perspective Delphi consensus study
Byrne, M., O’Connell, A., Egan, A. M., Dinneen, S. F., Hynes, L., O’Hara, M. C., Holt, R. I. G., Willaing, I., Vallis, M., Hendrieckx, C., et al. (2017) · Trials · doi:10.1186/s13063-017-2364-y · Cited by 84
Self-citation
Adjusting insulin doses in patients with type 1 diabetes who use insulin pump and continuous glucose monitoring: Variations among countries and physicians
Nimri, R., Dassau, E., Segall, T., Muller, I., Bratina, N., Kordonouri, O., Bello, R., Biester, T., Dovč, K., Tenenbaum, A., et al. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13408 · Cited by 79
SGLT inhibitor adjunct therapy in type 1 diabetes
McCrimmon, R. J., & Henry, R. R. (2018) · Diabetologia · doi:10.1007/s00125-018-4671-6 · Cited by 78
Glycemic control and complications in patients with type 1 diabetes - a registry-based longitudinal study of adolescents and young adults
Carlsen, S., Skrivarhaug, T., Thue, G., Cooper, J. G., Gøransson, L. G., Løvaas, K. F., & Sandberg, S. (2016) · Pediatric Diabetes · doi:10.1111/pedi.12372 · Cited by 78
Self-citation
Diabetic Cardiomyopathy and Ischemic Heart Disease: Prevention and Therapy by Exercise and Conditioning
Crisafulli, A., Pagliaro, P., Roberto, S., Cugusi, L., Mercuro, G., Lazou, A., Beauloye, C., Bertrand, L., Hausenloy, D. J., Aragno, M., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082896 · Cited by 81
A new perspective on metformin therapy in type 1 diabetes
on behalf of The REMOVAL Study Team, Livingstone, R., Boyle, J. G., & Petrie, J. R. (2017) · Diabetologia · doi:10.1007/s00125-017-4364-6 · Cited by 80
Establishment of the T1D Exchange Quality Improvement Collaborative (T1DX-QI)
Alonso, G. T., Corathers, S. D., Shah, A. C., Clements, M. A., Kamboj, M. K., Sonabend, R., DeSalvo, D. J., Mehta, S. N., CABRERA, A. B., Rioles, N. A., et al. (2020) · Clinical Diabetes · doi:10.2337/cd19-0032 · Cited by 75
Insulin Pump Therapy
Nimri, R., Nir, J., & Phillip, M. (2019) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000001097 · Cited by 76
Continuous Glucose Monitoring (CGM) Adherence in Youth With Type 1 Diabetes: Associations With Biomedical and Psychosocial Variables
Giani, E., Snelgrove, R. K., Volkening, L. K., & Laffel, L. M. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816676280 · Cited by 72
Continuous Glucose Monitoring Associated With Less Diabetes-Specific Emotional Distress and Lower A1c Among Adolescents With Type 1 Diabetes
Vesco, A. T., Jedraszko, A. M., Garza, K. P., & Weissberg-Benchell, J. A. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818766381 · Cited by 77
International comparison of glycaemic control in people with type 1 diabetes: an update and extension
Prigge, R., McKnight, J. A., Wild, S. H., Haynes, A., Jones, T. W., Davis, E. A., Rami-Merhar, B. M., Fritsch, M., Prchla, C., Lavens, A., et al. (2021) · Diabetic Medicine · doi:10.1111/dme.14766 · Cited by 72
Self-citation
Levels of type 1 diabetes care in children and adolescents for countries at varying resource levels
Ogle, G. D., Oettingen, J. E. V., Middlehurst, A. C., Hanås, R., & Orchard, T. J. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12801 · Cited by 70
Epidemiology of Type 1 Diabetes
Vanderniet, J. A., Jenkins, A. J., & Donaghue, K. C. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01762-w · Cited by 87
Glycaemic control trends in people with type 1 diabetes in Scotland 2004–2016
Mair, C., Wulaningsih, W., Jeyam, A., McGurnaghan, S. J., Blackbourn, L. A. K., Kennon, B., Leese, G., Lindsay, R. S., McCrimmon, R. J., McKnight, J. A., et al. (2019) · Diabetologia · doi:10.1007/s00125-019-4900-7 · Cited by 60
Self-citation
International benchmarking in type 1 diabetes: Large difference in childhood HbA1c between eight high‐income countries but similar rise during adolescence—A quality registry study
Anderzén, J., Hermann, J. M., Samuelsson, U., Charalampopoulos, D., Svensson, J., Skrivarhaug, T., Fröhlich-Reiterer, E. E., Maahs, D. M., Åkesson, K., Kapellen, T. M., et al. (2020) · Pediatric Diabetes · doi:10.1111/pedi.13014 · Cited by 60
Self-citation
Effect of metformin on glycaemic control in patients with type 1 diabetes: A meta-analysis of randomized controlled trials
Meng, H., Zhang, A., Liang, Y., Hao, J., Zhang, X., & Lu, J. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2983 · Cited by 56
A century past the discovery of insulin: global progress and challenges for type 1 diabetes among children and adolescents in low-income and middle-income countries
Bhutta, Z. A., Salam, R. A., Gomber, A., Lewis-Watts, L., Narang, T., Mbanya, J. C., & Alleyne, G. A. O. (2021) · The Lancet · doi:10.1016/s0140-6736(21)02247-9 · Cited by 61
Cardiovascular disease and type 1 diabetes: prevalence, prediction and management in an ageing population
Lee, S. I., Patel, M., Jones, C. M., & Narendran, P. (2015) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622315598502 · Cited by 58
The Process of Adaptation Following a New Diagnosis of Type 1 Diabetes in Adulthood: A Meta-Synthesis
Due‐Christensen, M., Zoffmann, V., Willaing, I., Hopkins, D., & Forbes, A. (2017) · Qualitative Health Research · doi:10.1177/1049732317745100 · Cited by 56
The role of telenursing in the management of Diabetes Type 1: A randomized controlled trial
Kotsani, K., Antonopoulou, V., Kountouri, A., Grammatiki, M., Rapti, E., Karras, S. Ν., Trakatelli, C., Tsaklis, P., Kazakos, K. A., & Kotsa, K. (2018) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2018.01.003 · Cited by 65
Effect of switching from intermittently scanned to real-time continuous glucose monitoring in adults with type 1 diabetes: 24-month results from the randomised ALERTT1 trial
Visser, M. M., Charleer, S., Fieuws, S., Block, C. E. M. D., Hilbrands, R., Huffel, L. V., Maes, T., Vanhaverbeke, G., Dirinck, E. L., Myngheer, N., et al. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00352-7 · Cited by 53
Diagnosis, Therapy and Follow-Up of Diabetes Mellitus in Children and Adolescents
Neu, A., Bürger-Büsing, J., Danne, T., Dost, A., Holder, M., Holl, R. W., Holterhus, P., Kapellen, T. M., Karges, B., Kordonouri, O., et al. (2019) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1018-8963 · Cited by 60
Self-citation
Possibilities and challenges of a large international benchmarking in pediatric diabetology-The SWEET experience
Witsch, M., Kosteria, I., Kordonouri, O., Alonso, G. T., Archinkova, M., Besançon, S., Birkebæk, N., Bratina, N., Cherubini, V., Hanås, R., et al. (2016) · Pediatric Diabetes · doi:10.1111/pedi.12432 · Cited by 52
Self-citation
Use of adjuvant pharmacotherapy in type 1 diabetes: international comparison of 49,996 individuals in the prospective diabetes follow-up and T1D exchange registries
Lyons, S. K., Hermann, J. M., Miller, K. M., Hofer, S. E., Foster, N. C., Rami-Merhar, B. M., Aleppo, G., Seufert, J., DiMeglio, L. A., Danne, T., et al. (2017) · Diabetes Care · doi:10.2337/dc17-0403 · Cited by 51
Self-citation
Targeting the receptor for advanced glycation end products (RAGE) in type 1 diabetes
Bagge, S. L., Fotheringham, A. K., Leung, S. S., & Forbes, J. M. (2020) · Medicinal Research Reviews · doi:10.1002/med.21654 · Cited by 54
Gender-Disparities in Adults with Type 1 Diabetes: More Than a Quality of Care Issue. A Cross-Sectional Observational Study from the AMD Annals Initiative
Manicardi, V., Russo, G. T., Napoli, A., Torlone, E., Volsi, P. L., Giorda, C. B., Musacchio, N., Nicolucci, A., SURACI, C., Lucisano, G., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162960 · Cited by 49
Influences on Technology Use and Efficacy in Type 1 Diabetes
Franklin, V. L. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816639315 · Cited by 49
Clinically meaningful and lasting HbA1c improvement rarely occurs after 5 years of type 1 diabetes: an argument for early, targeted and aggressive intervention following diagnosis
Nirantharakumar, K., Mohammed, N. I., Toulis, K. A., Thomas, G. N., & Narendran, P. (2018) · Diabetologia · doi:10.1007/s00125-018-4574-6 · Cited by 47
Combined SGLT1 and SGLT2 Inhibitors and Their Role in Diabetes Care
Danne, T., Biester, T., & Kordonouri, O. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0081 · Cited by 48
The role of socio-economic and clinical factors on HbA1c in children and adolescents with type 1 diabetes: an Italian multicentre survey
Gesuita, R., Skrami, E., Bonfanti, R., Cipriano, P., Ferrito, L., Frongia, P., Iafusco, D., Iannilli, A., Lombardo, F., Mozzillo, E., et al. (2016) · Pediatric Diabetes · doi:10.1111/pedi.12378 · Cited by 44
Self-citation
Pre‐school and school‐aged children benefit from the switch from a sensor‐augmented pump to an AndroidAPS hybrid closed loop: A retrospective analysis
Petruželková, L., Jiranova, P., Šoupal, J., Kozak, M., Plachý, L., Neuman, V., Průhová, Š., Obermannová, B., Koloušková, S., & Šumnı́k, Z. (2021) · Pediatric Diabetes · doi:10.1111/pedi.13190 · Cited by 43
Cohort profile: National Diabetes Audit for England and Wales
Holman, N., Knighton, P., Wild, S. H., Sattar, N. A., Dew, C., Gregg, E. W., Khunti, K. K., Valabhji, J., & Young, B. (2021) · Diabetic Medicine · doi:10.1111/dme.14616 · Cited by 43
Self-citation
Suboptimal glycemic control in adolescents and young adults with type 1 diabetes from 2011 to 2020 across Australia and New Zealand: Data from the Australasian Diabetes Data Network registry
James, S., Perry, L., LOWE, J. M., Harris, M., Craig, M. E., ADDN study group, Anderson, K. P., Andrikopoulos, S., Ambler, G. R., Barrett, H. L., et al. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13364 · Cited by 42
Self-citation
Do sex differences in paediatric type 1 diabetes care exist? A systematic review
de Vries, S. A. G., Verheugt, C. L., Mul, D., Nieuwdorp, M., & Sas, T. (2023) · Diabetologia · doi:10.1007/s00125-022-05866-4 · Cited by 41
Alpha-Lipoic Acid and Antioxidant Diet Help to Improve Endothelial Dysfunction in Adolescents with Type 1 Diabetes: A Pilot Trial
Scaramuzza, A. E., Giani, E., Redaelli, F. C., Ungheri, S., Macedoni, M., Giudici, V., Bosetti, A., Ferrari, M., & Zuccotti, G. (2015) · Journal of Diabetes Research · doi:10.1155/2015/474561 · Cited by 42
Young patients with type 1 diabetes poorly controlled and poorly compliant with self-monitoring of blood glucose: can technology help? Results of the i-NewTrend randomized clinical trial
Bartolo, P. D., Nicolucci, A., Cherubini, V., Iafusco, D., Scardapane, M., & Rossi, M. C. (2017) · Acta Diabetologica · doi:10.1007/s00592-017-0963-4 · Cited by 41
Self-citation
Adjustment of Insulin Pump Settings in Type 1 Diabetes Management: Advisor Pro Device Compared to Physicians’ Recommendations
Nimri, R., Oron, T., Muller, I., Kraljević, I., Alonso, M. M., Keskinen, P., Milicic, T. J., Oren, A., Christoforidis, A., den Brinker, M., et al. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820965561 · Cited by 41
Metformin in adults with type 1 diabetes: D esign and methods of REducing with MetfOrmin V ascular A dverse L esions ( REMOVAL ): A n international multicentre trial
Petrie, J. R., Chaturvedi, N., Ford, I., HRAMIAK, I. M., Hughes, A. D., Jenkins, A. J., Klein, B. E. K., Klein, R., Ooi, T. C., Rossing, P. R., et al. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12840 · Cited by 39
Effect of an Integrated, Multidisciplinary Nationwide Approach to Type 1 Diabetes Care on Metabolic Outcomes: An Observational Real-World Study
Lavens, A., Nobels, F. R. E., Block, C. E. M. D., Oriot, P., Verhaegen, A. A., Chao, S., Casteels, K., Mouraux, T., Doggen, K., Mathieu, C., et al. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0003 · Cited by 38
Hybrid Closed-Loop Systems for the Treatment of Type 1 Diabetes: A Collaborative, Expert Group Position Statement for Clinical Use in Central and Eastern Europe
Janež, A., Battelino, T., Klupa, T., Kocsis, G., Kuricova, M., Lalic, N. M., Stoian, A. P., Prázný, M., Rahelić, D., Šoupal, J., et al. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01160-5 · Cited by 44
Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT
Blair, J., McKay, A., Ridyard, C. H., Thornborough, K., Bedson, E., Peak, M., Didi, M., Annan, F., Gregory, J. W., Hughes, D. A., et al. (2018) · Health Technology Assessment · doi:10.3310/hta22420 · Cited by 39
Real-World Implications of Hybrid Close Loop (Hcl) Insulin Delivery System
Faulds, E. R., Zappe, J., & Dungan, K. M. (2019) · Endocrine Practice · doi:10.4158/ep-2018-0515 · Cited by 37
Diagnosis, Therapy and Follow-up of Diabetes Mellitus in Children and Adolescents
Neu, A., Bürger-Büsing, J., Danne, T., Dost, A., Holder, M., Holl, R. W., Holterhus, P., Kapellen, T. M., Karges, B., Kordonouri, O., et al. (2019) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0869-0210 · Cited by 36
Self-citation
Optimizing Postprandial Glucose Management in Adults With Insulin-Requiring Diabetes: Report and Recommendations
Leahy, J. L., Aleppo, G., Fonseca, V. A., Garg, S. K., Hirsch, I. B., McCall, A. L., McGill, J. B., & Polonsky, W. H. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00222 · Cited by 38
What is the value of faster acting prandial insulin? Focus on ultra rapid lispro
Heise, T., de Oliveira, C. P., Juneja, R., Ribeiro, A., Chigutsa, F. B., & Blevins, T. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14773 · Cited by 33
Glycaemic outcomes in Australasian children and adults with type 1 diabetes: failure to meet targets across the age spectrum
Holmes-Walker, D. J., Abraham, M. B., Chee, M., Jones, T. W., & Australasian Diabetes Data Network (ADDN) Study Group (2021) · Internal Medicine Journal · doi:10.1111/imj.15426 · Cited by 33
Self-citation
Costs of COVID-19 pandemic associated with diabetes in Europe: a health care cost model
Bain, S. C., Czernichow, S., Bøgelund, M., Madsen, M. E., Yssing, C., McMillan, A. C., Hvid, C. A., Hettiarachchige, N., & Panton, U. H. (2020) · Current Medical Research and Opinion · doi:10.1080/03007995.2020.1862775 · Cited by 33
Intestinal Microbiota in Common Chronic Inflammatory Disorders Affecting Children
Torun, A., Hupalowska, A., Trzonkowski, P., Kierkuś, J., & Pyrzyńska, B. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.642166 · Cited by 40
Effects of a low-carbohydrate diet in adults with type 1 diabetes management: A single arm non-randomised clinical trial
Turton, J. L., Brinkworth, G. D., Parker, H. M., Lim, D. M., Lee, K., Rush, A., Johnson, R., & Rooney, K. B. (2023) · PLoS ONE · doi:10.1371/journal.pone.0288440 · Cited by 36
Comparison of different insulin pump makes under routine care conditions in adults with Type 1 diabetes
Leelarathna, L., Roberts, S. A., Hindle, A., Markakis, K., Alam, T., Chapman, A., Morris, J., Urwin, A., Jinadev, P., & Rutter, M. K. (2017) · Diabetic Medicine · doi:10.1111/dme.13412 · Cited by 32
Dose‐dependent glycometabolic effects of sotagliflozin on type 1 diabetes over 12 weeks: The inTandem4 trial
Baker, C., Wason, S., Banks, P. L., Sawhney, S., Chang, A., Danne, T., Gesty‐Palmer, D., Kushner, J. A., McGuire, D. K., Mikell, F. L., et al. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13825 · Cited by 29
Glycaemic control and its associated factors in Chinese adults with type 1 diabetes mellitus
Liu, L., Yang, D., Zhang, Y., Lin, S., Zheng, X., Lin, S., Chen, L., Zhang, X., Li, L., Liang, G., et al. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2716 · Cited by 31
Precision Dosing of Rapid-Acting Insulin Matters
Aanstoot, H., Rodriguez, H., WEINZIMER, S. A., Vint, N., & Koeneman, L. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0374 · Cited by 30
Self-citation
Factors associated with glycemic control in type 1 diabetes patients in China: A cross‐sectional study
Huo, L., Deng, W., Shaw, J. E., Magliano, D. J., Zhang, P., McGuire, H., Kissimova‐Skarbek, K., Whiting, D. R., & Ji, L. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13282 · Cited by 30
Socioeconomic deprivation, technology use, C‐peptide, smoking and other predictors of glycaemic control in adults with type 1 diabetes
Dover, A. R., Strachan, M. W. J., McKnight, J. A., Stimson, R. H., Mackenzie, S. D., Lyall, M. J., Wright, R. J., Forbes, S., & Gibb, F. W. (2020) · Diabetic Medicine · doi:10.1111/dme.14445 · Cited by 32
Self-citation
Formation of a type 1 diabetes young adult patient and public involvement panel to develop a health behaviour change intervention: the D1 Now study
the D1 Now Type 1 Diabetes Young Adult Study Group, O’Hara, M. C., Cunningham, Á., Keighron, C. N., Allen, G., Caulfield, A., Duffy, C., Long, M., Mallon, M., Mullins, M., et al. (2017) · Research Involvement and Engagement · doi:10.1186/s40900-017-0068-9 · Cited by 30
Self-citation
Route to improving Type 1 diabetes mellitus glycaemic outcomes: real‐world evidence taken from the National Diabetes Audit
Heald, A. H., Livingston, M. A., Fryer, A. A., Moreno, G., Malipatil, N. S., Gadsby, R., Ollier, W., Lunt, M., Stedman, M., & Young, R. J. (2017) · Diabetic Medicine · doi:10.1111/dme.13541 · Cited by 29
Self-citation
Effect of 6 months of hybrid closed-loop insulin delivery in adults with type 1 diabetes: a randomised controlled trial protocol
McAuley, S. A., de Bock, M. I., Sundararajan, V., Lee, M. H., Paldus, B., Ambler, G. R., Bach, L. A., Burt, M. G., Cameron, F. J., Clarke, P., et al. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-020274 · Cited by 29
Self-citation
Worldwide differences in childhood type 1 diabetes: The SWEET experience
Saiyed, M., Hasnani, D., Alonso, G. T., Richmond, E., Besançon, S., Cotterill, A., Ngwu, U., Mazza, C., Rottembourg, D., Lanzinger, S., et al. (2021) · Pediatric Diabetes · doi:10.1111/pedi.13137 · Cited by 29
Sodium-glucose cotransporter 2 inhibitors as an add-on therapy to insulin for type 1 diabetes mellitus: meta-analysis of randomized controlled trials
Rao, L., Ren, C., Luo, S., Huang, C., & Li, X. (2021) · Acta Diabetologica · doi:10.1007/s00592-021-01686-x · Cited by 29
Gender Difference in Type 1 Diabetes: An Underevaluated Dimension of the Disease
Tatti, P., & Pavandeep, S. (2022) · Diabetology · doi:10.3390/diabetology3020027 · Cited by 29
Progress and challenges for treating Type 1 diabetes
Garyu, J., Meffre, E., Cotsapas, C. J., & Herold, K. C. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.04.004 · Cited by 30
Sex differences over time for glycemic control, pump use and insulin dose in patients aged 10–40 years with type 1 diabetes: a diabetes registry study
Boettcher, C., Tittel, S. R., Meißner, T., Gohlke, B. C., Stachow, R., Dost, A., Wunderlich, S., Lowack, I., & Lanzinger, S. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002494 · Cited by 28
Cost-Effectiveness Analysis of an Advanced Hybrid Closed-Loop Insulin Delivery System in People with Type 1 Diabetes in Greece
Lambadiari, V., Saltik, A. Z. O., de Portu, S., Buompensiere, M. I., Kountouri, A., Korakas, E., Sharland, H., & Cohen, O. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0443 · Cited by 30
Organization and regional distribution of centers for the management of children and adolescents with diabetes in Italy
Study Group for Diabetes of ISPED, Giorgetti, C., Ferrito, L., Zallocco, F., Iannilli, A., & Cherubini, V. (2015) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-015-0179-6 · Cited by 28
Self-citation
Does knowledge on diabetes management influence glycemic control? A nationwide study in patients with type 1 diabetes in Brazil
Gomes, M. B., Santos, D. C., Pizarro, M., Barros, B. S. V., Melo, L. G. N., & Negrato, C. A. (2018) · Patient Preference and Adherence · doi:10.2147/ppa.s146268 · Cited by 30

Authors: McKnight, J. A., Wild, S. H., Lamb, M. J. E., Cooper, M. N., Jones, T. W., Davis, E. A., Hofer, S., Fritsch, M., Schober, E., Svensson, J., Almdal, T., Young, R., Warner, J. T., Delemer, B., Souchon, P. F., Holl, R. W., Karges, W., Kieninger, D. M., Tigas, S., Bargiota, A., Sampanis, C., Cherubini, V., Gesuita, R., Strele, I., Pildava, S., Coppell, K. J., Magee, G., Cooper, J. G., Dinneen, S. F., Eeg‐Olofsson, K., Svensson, A. ‐., Gudbjornsdottir, S., Veeze, H., Aanstoot, H. ‐., Khalangot, M., Tamborlane, W. V., & Miller, K. M.
Affiliations: Western General Hospital (GB)
University of Edinburgh (GB)
The Kids Research Institute Australia (AU)
Innsbruck Medical University (AT)
Medical University of Vienna (AT)
Herlev Hospital (DK)
Copenhagen University Hospital (DK)
Salford Royal NHS Foundation Trust (GB)
Noah's Ark Children's Hospital for Wales (GB)
Université de Reims Champagne-Ardenne (FR)
Universität Ulm (DE)
RWTH Aachen University (DE)
Johannes Gutenberg University Mainz (DE)
University of Ioannina (GR)
Department of Endocrinology and Metabolic Diseases University of Thessaly Greece
Aristotle University of Thessaloniki (GR)
Fondazione Ospedale Salesi (IT)
Marche Polytechnic University (IT)
Department of Public Health and Epidemiology Riga Stradins University Riga Latvia
The Centre for Disease Prevention and Control of Latvia Riga Latvia
University of Otago (NZ)
Daisy Hill Hospital (GB)
Norwegian Adult Diabetes Register, Noklus Bergen Norway
Ollscoil na Gaillimhe – University of Galway (IE)
Sahlgrenska University Hospital (SE)
Centre of Registers Vastra Gotaland (SE)
Department of Medicine Sahlgrenska University Hospital University of Gothenburg Göteborg Sweden
Diabeter National Centre for Pediatric and Adolescent Diabetes Rotterdam the Netherlands
V.P. Komisarenko Institute of Endocrinology and Metabolism (UA)
Yale University (US)
T1D Exchange (US)
Corresponding author: McKnight, J. A.
ORCID: McKnight, J. A.
Wild, S. H.
Lamb, M. J. E.
Cooper, M. N.
Jones, T. W.
Davis, E. A.
Hofer, S.
Fritsch, M.
Svensson, J.
Almdal, T.
Delemer, B.
Holl, R. W.
Tigas, S.
Cherubini, V.
Gesuita, R.
Pildava, S.
Coppell, K. J.
Cooper, J. G.
Dinneen, S. F.
Eeg‐Olofsson, K.
Veeze, H.
Aanstoot, H.‐J.
Khalangot, M.
Tamborlane, W. V.
Miller, K. M.
Venue: Diabetic Medicine
Publisher: Wiley
Published: 2015-02-21
Volume: 32
Issue: 8
Pages: 1036-1050
ISSN: 0742-3071 (ISSN-L)
1464-5491
DOI: 10.1111/dme.12676
OpenAlex: W2167121109
Cited by: 343
References: 18
Citations by year: 2026: 6 · 2025: 19 · 2024: 19 · 2023: 22 · 2022: 35 · 2021: 52 · 2020: 39 · 2019: 40 · 2018: 42 · 2017: 34 · 2016: 19 · 2015: 13
FWCI: 17.71
Type: journal article
Language: en
Open access: green
research-repository.uwa.edu.au
Licence: other-oa
onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: Diabetic Medicine (publishedVersion)
UWA Profiles and Research Repository (UWA) (publishedVersion, other-oa)
PubMed (publishedVersion)
ARAN (University of Galway Research Repository) (Ollscoil na Gaillimhe – University of Galway) (acceptedVersion, cc-by-nc-nd)
Arrow@dit (Dublin Institute of Technology) (submittedVersion)
ARAN (University of Galway Research Repository) (Ollscoil na Gaillimhe – University of Galway) (submittedVersion, cc-by-nc-nd)
University of Thessaly Institutional Repository (University of Thessaly) (submittedVersion)
Università Politecnica delle Marche (Università Politecnica delle Marche) (submittedVersion)
RWTH Publications (RWTH Aachen) (submittedVersion)
Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
ARAN (University of Galway Research Repository) (Ollscoil na Gaillimhe – University of Galway) (submittedVersion, cc-by-nc)
Research Repository UCD (University College Dublin) (cc-by-nc)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
Keywords: type 1 diabetes, glycemic control, HbA1c, cross-national comparison, diabetes registry, insulin pump therapy, young adults, sex differences, age differences
MeSH terms: Adolescent, Adult, Austria, Denmark, Diabetes Mellitus, Type 1, England, Female, France, Germany, Greece, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Insulin, Insulin Infusion Systems, Ireland, Italy, Latvia, Male, Netherlands, New Zealand, Northern Ireland, Norway, Registries, Scotland, Sweden, Ukraine, United States, Wales, Western Australia, Practice Guidelines as Topic, Guideline Adherence, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Glycaemic control of Type 1 diabetes in clinical practice early in the 21st century: an international comparison

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks